Clinical Categorical Courses
Monday, 23 April - Friday, 27 April
Last updated 20 January 2009
Cardiac MRI: Sessions I and II
Monday, 23 April, 11:00 - 13:00, and Wednesday, 25 April, 10:30 - 12:30
Zahi A. Fayad and Cynthia B. Paschal, Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
  • Explain and apply MR protocols for determination of cardiac morphology, dynamic function, flow and physiologic status;
  • Describe methodology and interpret results for cardiac MR assessment of acquired and congenital cardiac disease;
  • Compare approaches for optimal presentation and analysis of cardiac MR results.
Monday, 23 April, 11:00 - 13:00:  Session I
11:00 Introduction Dudley J. Pennell
11:25 Congenital Heart Disease Albert de Roos
11:50 MR Coronary Angiography John N. Oshinski
12:15 Atherosclerotic Plaque Characterization Zahi A. Fayad
12:50 Discussion
13:00 Adjournment
Wednesday, 25 April, 10:30 - 12:30:  Session II
10:30 Assessment of Myocardial Function Jorg Barkhausen
10:55 Assessing Myocardial Perfusion and Stress Function Steven Wolff
11:20 Determining Myocardial Viability Joao A.C. Lima
11:45 Quantitative Image Analysis Elliott R. McVeigh
12:10 Discussion
12:30 Adjournment
Oncologic MR Imaging
Tuesday, 24 April, 10:30 - 12:30
Jelle O. Barentsz and Jeffrey L. Evelhoch, Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
  • Apply state-of-the-art methodology for the detection and staging of cancer;
  • Describe benefits of using USIOP for detection of nodal metastases;
  • Explain how MR can be used to improve response assessment;
  • Appraise the potential for spectroscopic imaging to increase the utility of MR in oncology.
10:30 Cancer Detection and Staging Mitchell D. Schnall
10:55 Detection of Nodal Metastases Jelle O. Barentsz
11:20 Response Assessment Anwar R. Padhani
11:45 Role of Spectroscopic Imaging Hedvig Hricak
12:10 Discussion
12:30 Adjournment
Marrow Imaging
Wednesday, 25 April, 10:30 - 12:30
Mark Schweitzer and Bruno van de Berg, Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
  • Recognize the patterns of marrow edema and how to discriminate between the different causes of this condition;
  • Identify the characteristics of osteomyelitis in the patient who has neuropathic arthropathy;
  • List the different types of traumatic disorders of marrow;
  • Recognize the different patterns of marrow findings in multiple myeloma on MR.
10:30 MR of Osteomyelitis and Neuroarthropathy William B. Morrison
10:55 MR of Traumatic Marrow Disorders Mark Schweitzer
11:20 MR of Multiple Myeloma Bruno van de Berg
11:45 MR of Primary Bone Tumors Mark Davies
12:10 Discussion
12:30 Adjournment
Brain Spectroscopy
Thursday, 26 April, 10:30 - 12:30
John R. Griffiths and Sarah J. Nelson, Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
  • Identify situations where MRS may be valuable in the assessment of neurological diseases;
  • Select the most appropriate techniques for such applications;
  • Identify metabolites in spectra from normal and diseased brain tissue;
  • Recognize common spectral artifacts and distinguish them from regions of pathology.
10:30 MRS in Routine Radiology of Brain Masses Antoni Capdevila
11:00 MRSI for Planning Focal Radiation Therapy Sarah J. Nelson
11:30 Monitoring Pediatric Brain Disorders with MRS Arend Heerschap
12:00 MRS of Multiple Sclerosis David H. Miller
12:30 Adjournment

 

Breast MR Imaging
Friday, 27 April, 10:30 - 12:30
Susan M. Ascher and Christiane K. Kuhl, Organizers
Educational Objectives:  Upon completion of this session, participants should be able to:
  • Define important technical implications for performing breast MRI;
  • Identify appropriate indications for breast MRI, and how they compare to other modalities;
  • Explain imaging findings based on the International Working Group on Breast MRI's lexicon;
  • List specific diagnostic criteria used in breast MRI interpretation;
  • Recognize breast MRI features of benign and malignant breast diseases (to include invasive breast cancer and DCIS).
10:30 Introduction Debra M. Ikeda
10:50 Technical Aspects Nola Hylton
11:10 Image Interpretation Guidelines Christiane K. Kuhl
11:30 Diagnostic Accuracy Compared to Conventional Imaging Uwe Fischer
11:50 Established and Evolving Applications Mitchell D. Schnall
12:10 MR-Guided Interventional Therapy Steven E. Harms
12:30 Adjournment

Back to ISMRM/ESMRMB Meeting Menu. . .